[96a5a0]: / output / chiaCancer / identified / NCT02691793_identified.json

Download this file

516 lines (516 with data), 20.6 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
{
"info": {
"nct_id": "NCT02691793",
"official_title": "Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid Tumors",
"inclusion_criteria": "* Provision of fully informed consent prior to study specific procedures.\n* Patients must be >= 19 years of age\n* RET fusion positive or FGFR2 fusion/other FGFR mutation Refractory solid tumor and/or specific sensitivity to Sunitinib by Avatar scan that has progressed following standard therapy or that has not responded to standard therapy or for which there is no standard therapy.\n* ECOG Performance status0-2\n* Have measurable or evaluated disease based on RECIST 1.1 as determined by investigator.\n* Adequate Organ Function Laboratory values\n\n * Absolute neutrophil count >= 1.5 x 109/L, Hemoglobin >= 9g/dL, Platelets>=100 x 109/L Bilirubin <= 1.5 x upper limit of normal AST/ALT <= 2.5 X upper limit of normal(5.0 x upper limit of normal, for subject with liver metastases) Creatinine<= 1.5 X UNL\n* Patients of child-bearing potential should be using adequate contraceptive measures should not be breast feeding and must have a negative pregnancy test prior to start of dosing\n* Adequate heart function\nHealthy volunteers allowed\nMust have minimum age of 19 Years",
"exclusion_criteria": "* Patients with second primary cancer, except:adequately treated non-melanoma skin cancer, curatively treated in-situ cancer of the cervix, or other solid tumor curatively treated with no evidence of disease for <= 5 years.\n* Has known active central nervous system(CNS) metastases\n* Has an active infection requiring systemic therapy\n* Pregnancy or breast feeding\n* Patients with cardiac problem\n* Any previous treatment with sunitinib",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Provision of fully informed consent prior to study specific procedures.",
"criterions": [
{
"exact_snippets": [
"Provision of fully informed consent"
],
"criterion": "informed consent",
"requirement_type": "provision",
"expected_value": true
}
]
},
{
"line": "* Patients must be >= 19 years of age",
"criterions": [
{
"exact_snippets": [
"Patients must be >= 19 years of age"
],
"criterion": "age",
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 19
}
]
}
}
]
},
{
"line": "* RET fusion positive or FGFR2 fusion/other FGFR mutation Refractory solid tumor and/or specific sensitivity to Sunitinib by Avatar scan that has progressed following standard therapy or that has not responded to standard therapy or for which there is no standard therapy.",
"criterions": [
{
"exact_snippets": [
"RET fusion positive"
],
"criterion": "RET fusion",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"FGFR2 fusion/other FGFR mutation"
],
"criterion": "FGFR2 fusion",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"FGFR2 fusion/other FGFR mutation"
],
"criterion": "FGFR mutation",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"Refractory solid tumor"
],
"criterion": "solid tumor",
"requirement_type": "refractory",
"expected_value": true
},
{
"exact_snippets": [
"specific sensitivity to Sunitinib by Avatar scan"
],
"criterion": "sensitivity to Sunitinib",
"requirement_type": "specific",
"expected_value": true
},
{
"exact_snippets": [
"progressed following standard therapy"
],
"criterion": "progression after standard therapy",
"requirement_type": "occurrence",
"expected_value": true
},
{
"exact_snippets": [
"has not responded to standard therapy"
],
"criterion": "response to standard therapy",
"requirement_type": "lack of response",
"expected_value": true
},
{
"exact_snippets": [
"for which there is no standard therapy"
],
"criterion": "standard therapy availability",
"requirement_type": "availability",
"expected_value": false
}
]
},
{
"line": "* ECOG Performance status0-2",
"criterions": [
{
"exact_snippets": [
"ECOG Performance status",
"0-2"
],
"criterion": "ECOG Performance status",
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0
},
{
"operator": "<=",
"value": 2
}
]
}
}
]
},
{
"line": "* Have measurable or evaluated disease based on RECIST 1.1 as determined by investigator.",
"criterions": [
{
"exact_snippets": [
"measurable or evaluated disease"
],
"criterion": "disease",
"requirement_type": "measurability",
"expected_value": [
"measurable",
"evaluated"
]
},
{
"exact_snippets": [
"based on RECIST 1.1"
],
"criterion": "RECIST 1.1",
"requirement_type": "compliance",
"expected_value": true
},
{
"exact_snippets": [
"as determined by investigator"
],
"criterion": "investigator determination",
"requirement_type": "necessity",
"expected_value": true
}
]
},
{
"line": "* Adequate Organ Function Laboratory values",
"criterions": [
{
"exact_snippets": [
"Adequate Organ Function Laboratory values"
],
"criterion": "organ function",
"requirement_type": "adequacy",
"expected_value": true
}
]
},
{
"line": "* Absolute neutrophil count >= 1.5 x 109/L, Hemoglobin >= 9g/dL, Platelets>=100 x 109/L Bilirubin <= 1.5 x upper limit of normal AST/ALT <= 2.5 X upper limit of normal(5.0 x upper limit of normal, for subject with liver metastases) Creatinine<= 1.5 X UNL",
"criterions": [
{
"exact_snippets": [
"Absolute neutrophil count >= 1.5 x 109/L"
],
"criterion": "absolute neutrophil count",
"requirement_type": "quantity",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 1.5
}
]
}
},
{
"exact_snippets": [
"Hemoglobin >= 9g/dL"
],
"criterion": "hemoglobin",
"requirement_type": "quantity",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 9
}
]
}
},
{
"exact_snippets": [
"Platelets>=100 x 109/L"
],
"criterion": "platelets",
"requirement_type": "quantity",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 100
}
]
}
},
{
"exact_snippets": [
"Bilirubin <= 1.5 x upper limit of normal"
],
"criterion": "bilirubin",
"requirement_type": "quantity",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 1.5
}
]
}
},
{
"exact_snippets": [
"AST/ALT <= 2.5 X upper limit of normal"
],
"criterion": "AST/ALT",
"requirement_type": "quantity",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 2.5
}
]
}
},
{
"exact_snippets": [
"AST/ALT <= 2.5 X upper limit of normal",
"(5.0 x upper limit of normal, for subject with liver metastases)"
],
"criterion": "AST/ALT",
"requirement_type": "quantity",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 5.0
}
]
}
},
{
"exact_snippets": [
"Creatinine<= 1.5 X UNL"
],
"criterion": "creatinine",
"requirement_type": "quantity",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 1.5
}
]
}
}
]
},
{
"line": "* Patients of child-bearing potential should be using adequate contraceptive measures should not be breast feeding and must have a negative pregnancy test prior to start of dosing",
"criterions": [
{
"exact_snippets": [
"Patients of child-bearing potential"
],
"criterion": "child-bearing potential",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"using adequate contraceptive measures"
],
"criterion": "contraceptive measures",
"requirement_type": "usage",
"expected_value": true
},
{
"exact_snippets": [
"should not be breast feeding"
],
"criterion": "breast feeding",
"requirement_type": "status",
"expected_value": false
},
{
"exact_snippets": [
"must have a negative pregnancy test"
],
"criterion": "pregnancy test",
"requirement_type": "result",
"expected_value": "negative"
}
]
},
{
"line": "* Adequate heart function",
"criterions": [
{
"exact_snippets": [
"Adequate heart function"
],
"criterion": "heart function",
"requirement_type": "adequacy",
"expected_value": true
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": [
"Healthy volunteers allowed"
],
"criterion": "healthy volunteers",
"requirement_type": "participation",
"expected_value": true
}
]
},
{
"line": "Must have minimum age of 19 Years",
"criterions": [
{
"exact_snippets": [
"minimum age of 19 Years"
],
"criterion": "age",
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 19
}
}
]
}
],
"exclusion_lines": [
{
"line": "* Patients with second primary cancer, except:adequately treated non-melanoma skin cancer, curatively treated in-situ cancer of the cervix, or other solid tumor curatively treated with no evidence of disease for <= 5 years.",
"criterions": [
{
"exact_snippets": [
"second primary cancer"
],
"criterion": "second primary cancer",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"adequately treated non-melanoma skin cancer"
],
"criterion": "non-melanoma skin cancer",
"requirement_type": "treatment status",
"expected_value": "adequately treated"
},
{
"exact_snippets": [
"curatively treated in-situ cancer of the cervix"
],
"criterion": "in-situ cancer of the cervix",
"requirement_type": "treatment status",
"expected_value": "curatively treated"
},
{
"exact_snippets": [
"other solid tumor",
"curatively treated",
"no evidence of disease for <= 5 years"
],
"criterion": "other solid tumor",
"requirement_type": "treatment status",
"expected_value": "curatively treated"
},
{
"exact_snippets": [
"other solid tumor",
"curatively treated",
"no evidence of disease for <= 5 years"
],
"criterion": "other solid tumor",
"requirement_type": "disease evidence",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 5
}
]
}
}
]
},
{
"line": "* Has known active central nervous system(CNS) metastases",
"criterions": [
{
"exact_snippets": [
"known active central nervous system(CNS) metastases"
],
"criterion": "central nervous system metastases",
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"line": "* Has an active infection requiring systemic therapy",
"criterions": [
{
"exact_snippets": [
"active infection"
],
"criterion": "infection",
"requirement_type": "activity",
"expected_value": true
},
{
"exact_snippets": [
"requiring systemic therapy"
],
"criterion": "systemic therapy",
"requirement_type": "necessity",
"expected_value": true
}
]
},
{
"line": "* Pregnancy or breast feeding",
"criterions": [
{
"exact_snippets": [
"Pregnancy"
],
"criterion": "pregnancy",
"requirement_type": "presence",
"expected_value": false
},
{
"exact_snippets": [
"breast feeding"
],
"criterion": "breast feeding",
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"line": "* Patients with cardiac problem",
"criterions": [
{
"exact_snippets": [
"cardiac problem"
],
"criterion": "cardiac problem",
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"line": "* Any previous treatment with sunitinib",
"criterions": [
{
"exact_snippets": [
"previous treatment with sunitinib"
],
"criterion": "sunitinib treatment",
"requirement_type": "history",
"expected_value": true
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}